Pharm Stat/Eli Lilly FALL 2001 SEMINAR SERIES
STAT 598E: Statistical Applications in Pharmaceutical Research and Development
Mondays, 4:30 PM, LAEB B222
This special seminar series, which focuses on statistical methods and issues in the pharmaceutical industry, is a joint initiative between the Statistical and Mathematical Sciences Department of Eli Lilly & Company and the Department of Statistics of Purdue University at West Lafayette, Indiana. The lectures will be given by a team of Eli Lilly statisticians.
The goal of the series is to introduce students and faculty at the university to the broad spectrum of issues surrounding the drug development process in a pharmaceutical industry. The gamut of activities covering discovery, development, manufacturing, and marketing of pharmaceutical agents will be discussed. The statistical content of the seminars will be directed to students knowledgeable about statistics as well as the general interested audience.
The series is also offered as a one credit course, labeled STAT 598E, for Fall 2001 at Purdue. The instructor and coordinator is Professor M.E. Bock and the prerequisite is an introductory statistics course. The course meets Mondays, 4:30 PM, in LAEB B222. For further information, please contact Professor Bock by email at mbock@stat.purdue.edu or by phone at 765-494-3141.
The first seminar is Monday, August 20, 2001, 4:30 PM, LAEB B222.
Schedule
- Monday, August 20, 2001, 4:30 PM in LAEB B222
- Dr. J. P. Wery, Eli Lilly
& Company
Overview of Drug Discovery and Development. Role of Statistics and Information Sciences
- Monday, August 27, 2001, 4:30 PM in LAEB B222
- Dr. Ann Marie Crawford, Eli
Lilly & Company
Drug Hunting: Impact and Influence of Statistical Science on Regulated Drug Development
- Monday, September 10, 2001, 4:30 PM in LAEB B222
- Dr. Richard Higgs, Eli
Lilly & Company
Statistical Perspectives for Molecular Diversity
- Monday, September 17, 2001, 4:30 PM in LAEB B222
- Dr. Wendell Smith, Eli
Lilly & Company
Statistical Methods in Assay Validation
- Monday, September 24, 2001, 4:30 PM in LAEB B222
- Dr. Brian Smith, Eli Lilly
& Company
Clinical Pharmacology Statistics
- Monday, October 1, 2001, 4:30 PM in LAEB B222
- Dr. Doug Faries, Eli Lilly
& Company
Statistical Issues in Phase II Trials: Reaching a Product Decision
- Monday, October 8, 2001
- No Seminar
October Break
- Monday, October 15, 2001, 4:30 PM in LAEB B222
- Dr. Jay Andersen, Eli Lilly
& Company
Applications of Decision Analysis in the Pharmaceutical Industry
- Monday, October 22, 2001, 4:30 PM in LAEB B222
- Dr. Kristi Griffiths, Eli
Lilly & Company
A Statistician's Role in Drug Product Development
- Monday, October 29, 2001, 4:30 PM in LAEB B222
- Wherly P Hoffman, Ph.D. and
Daniel Ness, DVM, Ph.D., Eli Lilly &
Company
Statistics in Toxicology
- Monday, November 5, 2001, 4:30 PM in LAEB B222
- Dr. Roy Tamura, Eli Lilly
& Company
Comparing the Time to Response in Antidepressant Clinical Trials
Presentation Slides (PowerPoint)
- Monday, November 12, 2001, 4:30 PM in LAEB B222
- Dr. Bill Huster, Eli Lilly
& Company
From Product Decision to Regulatory Submission (and beyond!)
- Monday, November 19, 2001, 4:30 PM in LAEB B222
- Dr. Bob Obenchain, Eli
Lilly & Company
Adjustment for Treatment Selection Bias in Retrospective Studies
- Monday, November 26, 2001, 4:30 PM in LAEB B222
- Rebecca Elliott, Eli Lilly
& Company
Dose Control in Parenteral Manufacturing
- Monday, December 3, 2001, 4:30 PM in LAEB B222
- Dan Lockhart, Ph.D., Eli
Lilly & Company
Applications of Statistics in Pharmaceutical Marketing Research
